Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 15 | 2018 | 383 | 2.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2020 | 1428 | 2.210 |
Why?
|
| Brain | 18 | 2018 | 971 | 2.020 |
Why?
|
| Cognition | 13 | 2020 | 551 | 1.620 |
Why?
|
| Aging | 8 | 2015 | 953 | 1.520 |
Why?
|
| Auditory Perception | 8 | 2009 | 80 | 1.200 |
Why?
|
| Attention | 6 | 2009 | 83 | 1.130 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2018 | 1345 | 0.970 |
Why?
|
| Visual Perception | 7 | 2009 | 115 | 0.870 |
Why?
|
| Caloric Restriction | 2 | 2019 | 96 | 0.780 |
Why?
|
| Neuropsychological Tests | 12 | 2019 | 379 | 0.650 |
Why?
|
| Aged | 30 | 2020 | 10398 | 0.600 |
Why?
|
| Obesity | 3 | 2019 | 1164 | 0.590 |
Why?
|
| Exercise | 2 | 2019 | 655 | 0.580 |
Why?
|
| Exercise Therapy | 1 | 2019 | 259 | 0.560 |
Why?
|
| Female | 35 | 2020 | 20126 | 0.470 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 64 | 0.470 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2013 | 3 | 0.460 |
Why?
|
| Humans | 41 | 2020 | 32297 | 0.450 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 54 | 0.440 |
Why?
|
| Pain | 1 | 2015 | 305 | 0.430 |
Why?
|
| Middle Aged | 26 | 2020 | 11949 | 0.420 |
Why?
|
| Mobility Limitation | 1 | 2014 | 221 | 0.410 |
Why?
|
| Male | 30 | 2019 | 19488 | 0.400 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 31 | 0.400 |
Why?
|
| African Americans | 8 | 2018 | 1443 | 0.400 |
Why?
|
| Adult | 19 | 2016 | 9467 | 0.390 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 137 | 0.380 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 397 | 0.370 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 351 | 0.340 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2007 | 121 | 0.340 |
Why?
|
| Sensation | 1 | 2009 | 55 | 0.320 |
Why?
|
| Acoustic Stimulation | 7 | 2009 | 125 | 0.320 |
Why?
|
| Photic Stimulation | 7 | 2009 | 159 | 0.320 |
Why?
|
| Cues | 4 | 2009 | 70 | 0.310 |
Why?
|
| Dementia | 3 | 2015 | 256 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 293 | 0.310 |
Why?
|
| Brain Mapping | 5 | 2014 | 178 | 0.300 |
Why?
|
| Biomedical Research | 1 | 2008 | 169 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 133 | 0.280 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2015 | 188 | 0.240 |
Why?
|
| Risk Factors | 8 | 2018 | 3876 | 0.240 |
Why?
|
| Genotype | 3 | 2020 | 742 | 0.220 |
Why?
|
| Reaction Time | 5 | 2009 | 118 | 0.220 |
Why?
|
| Brain Diseases | 2 | 2014 | 39 | 0.210 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1522 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 1092 | 0.210 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 560 | 0.210 |
Why?
|
| Organ Size | 5 | 2018 | 220 | 0.210 |
Why?
|
| European Continental Ancestry Group | 6 | 2018 | 1180 | 0.210 |
Why?
|
| Albuminuria | 4 | 2017 | 181 | 0.210 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 4050 | 0.180 |
Why?
|
| Life Style | 2 | 2020 | 404 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2014 | 117 | 0.180 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 147 | 0.180 |
Why?
|
| Diabetes Complications | 3 | 2018 | 180 | 0.180 |
Why?
|
| Auditory Cortex | 3 | 2009 | 21 | 0.180 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 62 | 0.180 |
Why?
|
| Cohort Studies | 7 | 2018 | 1832 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2009 | 470 | 0.170 |
Why?
|
| Menopause | 1 | 2020 | 92 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2019 | 496 | 0.170 |
Why?
|
| Executive Function | 1 | 2019 | 57 | 0.170 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 53 | 0.170 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1133 | 0.160 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2015 | 128 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2018 | 176 | 0.150 |
Why?
|
| Weight Loss | 1 | 2020 | 454 | 0.140 |
Why?
|
| Postmenopause | 2 | 2015 | 409 | 0.140 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.140 |
Why?
|
| Overweight | 1 | 2018 | 270 | 0.140 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 99 | 0.140 |
Why?
|
| Young Adult | 3 | 2014 | 2626 | 0.130 |
Why?
|
| Spectrin | 1 | 2014 | 5 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 12 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2015 | 66 | 0.120 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 35 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 55 | 0.120 |
Why?
|
| Prevalence | 2 | 2018 | 986 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 4 | 2017 | 309 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 849 | 0.120 |
Why?
|
| Anxiety | 1 | 2015 | 185 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 101 | 0.110 |
Why?
|
| Dopamine | 1 | 2016 | 232 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 18 | 0.110 |
Why?
|
| Nerve Net | 1 | 2014 | 122 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 225 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2016 | 701 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 786 | 0.100 |
Why?
|
| Visual Cortex | 2 | 2009 | 35 | 0.100 |
Why?
|
| Depression | 1 | 2015 | 436 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2013 | 137 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 41 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3358 | 0.100 |
Why?
|
| United States | 6 | 2018 | 3983 | 0.100 |
Why?
|
| Fatty Acid Desaturases | 1 | 2011 | 48 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 759 | 0.100 |
Why?
|
| Computational Biology | 1 | 2011 | 90 | 0.090 |
Why?
|
| Science | 1 | 2010 | 9 | 0.090 |
Why?
|
| Ethics, Research | 1 | 2010 | 25 | 0.090 |
Why?
|
| Social Responsibility | 1 | 2010 | 14 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 1523 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2013 | 339 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 541 | 0.090 |
Why?
|
| Teaching | 1 | 2010 | 62 | 0.090 |
Why?
|
| Research | 1 | 2010 | 77 | 0.090 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 5 | 0.090 |
Why?
|
| Noise | 1 | 2009 | 7 | 0.090 |
Why?
|
| Space Perception | 1 | 2009 | 27 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.080 |
Why?
|
| Environment | 1 | 2009 | 52 | 0.080 |
Why?
|
| Laboratories | 1 | 2008 | 16 | 0.080 |
Why?
|
| Behavior | 1 | 2008 | 31 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 57 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 98 | 0.080 |
Why?
|
| Curriculum | 1 | 2010 | 210 | 0.080 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2007 | 5 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2007 | 28 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2007 | 15 | 0.070 |
Why?
|
| Mental Processes | 1 | 2007 | 17 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 244 | 0.070 |
Why?
|
| Adolescent | 4 | 2009 | 3571 | 0.070 |
Why?
|
| Perception | 1 | 2007 | 98 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 1204 | 0.070 |
Why?
|
| Creatinine | 2 | 2017 | 200 | 0.070 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 144 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 454 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 106 | 0.060 |
Why?
|
| Hypertension | 3 | 2017 | 972 | 0.060 |
Why?
|
| Risk | 2 | 2015 | 325 | 0.060 |
Why?
|
| Animals | 1 | 2015 | 7694 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 511 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2011 | 13 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2011 | 221 | 0.050 |
Why?
|
| Fatigue | 1 | 2019 | 85 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 150 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 225 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 123 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2019 | 236 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2018 | 102 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 172 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2016 | 8 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 141 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 921 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 99 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 696 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 79 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 93 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 97 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 191 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 46 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 50 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 2181 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 177 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 174 | 0.030 |
Why?
|
| Educational Status | 1 | 2014 | 177 | 0.030 |
Why?
|
| Smoking | 1 | 2017 | 493 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 120 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 911 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 18 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 656 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 171 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1207 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 28 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 25 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 51 | 0.020 |
Why?
|
| Family Health | 1 | 2011 | 77 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 192 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1520 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2010 | 3 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 877 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2296 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 57 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 635 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 296 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 39 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 255 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 110 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 176 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2007 | 220 | 0.020 |
Why?
|